XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
shares in Thousands, $ in Thousands
Total
2022 Notes
2025 Notes
Series E preferred stock
Common shares
Preferred Stock
Preferred Stock
Series E preferred stock
Common Stock
Common Stock
2022 Notes
Common Stock
2025 Notes
Common Stock
Common shares
Additional Paid-in Capital
Additional Paid-in Capital
2022 Notes
Additional Paid-in Capital
2025 Notes
Additional Paid-in Capital
Series E preferred stock
Additional Paid-in Capital
Common shares
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Noncontrolling Interests
Beginning balance at Dec. 31, 2019 $ (37,358)         $ 0   $ 82       $ 584,862         $ (3,879) $ (618,303) $ (120)
Beginning Balance (shares) at Dec. 31, 2019           10   81,974                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Net income (loss) (98,441)                                 (98,470) 29
Foreign currency translation adjustment (10,734)                               (10,734)    
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan 3,198             $ 2       3,196              
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan (shares)               1,471                      
Taxes withheld on net settled vesting of restricted stock units (326)                     (326)              
Issuance of common shares under settlement agreement 972                     972              
Issuance of common shares under settlement agreement (in shares)               90                      
Issuance of common shares in connection with conversion or exchange of notes   $ 66,088 $ 14,354           $ 14 $ 1     $ 66,074 $ 14,353          
Issuance of common shares in connection with conversion or exchange of notes (shares)                 13,739 1,177                  
Issuance of shares       $ 25,000                     $ 25,000        
Issuance of shares (shares)             25                        
Share-based compensation 8,188                     8,188              
Series E preferred stock dividends 0                     2,056           (2,056)  
Issuance of Series E preferred stock in lieu of interest       2,330                     2,330        
Issuance of Series E preferred stock in lieu of interest (shares)             2                        
Repurchase of Series E preferred stock       $ (2,354)                     $ (2,354)        
Repurchase of Series E preferred stock (shares)             (2)                        
Exercise of warrants 1,861                     1,861              
Exercise of warrants (shares)               338                      
Ending balance at Sep. 30, 2020 (27,222)         $ 0   $ 99       706,212         (14,613) (718,829) (91)
Ending Balance (shares) at Sep. 30, 2020           35   98,789                      
Beginning balance at Jun. 30, 2020 (41,928)         $ 0   $ 97       686,410         (15,783) (712,558) (94)
Beginning Balance (shares) at Jun. 30, 2020           35   97,018                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Net income (loss) (5,439)                                 (5,442) 3
Foreign currency translation adjustment 1,170                               1,170    
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan 1,486             $ 1       1,485              
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan (shares)               504                      
Taxes withheld on net settled vesting of restricted stock units (45)                     (45)              
Issuance of common shares under settlement agreement 972                     972              
Issuance of common shares under settlement agreement (in shares)               90                      
Issuance of common shares in connection with conversion or exchange of notes   1 $ 14,354             $ 1     1 $ 14,353          
Issuance of common shares in connection with conversion or exchange of notes (shares)                   1,177                  
Share-based compensation 2,207                     2,207              
Series E preferred stock dividends 0                     829           (829)  
Ending balance at Sep. 30, 2020 (27,222)         $ 0   $ 99       706,212         (14,613) (718,829) (91)
Ending Balance (shares) at Sep. 30, 2020           35   98,789                      
Beginning balance at Dec. 31, 2020 (27,899)         $ 0   $ 99       711,487         (6,972) (732,422) (91)
Beginning Balance (shares) at Dec. 31, 2020           35   99,399                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Net income (loss) (37,191)                                 (37,405) 214
Foreign currency translation adjustment (1,878)                               (1,878)    
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan 3,537             $ 2       3,535              
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan (shares)               2,081                      
Taxes withheld on net settled vesting of restricted stock units (1,105)                     (1,105)              
Issuance of common shares in connection with conversion or exchange of notes   $ 5,382             $ 0       $ 5,382            
Issuance of common shares in connection with conversion or exchange of notes (shares)                 429                    
Issuance of shares         $ 29,370           $ 2         $ 29,368      
Issuance of shares (shares)                     1,516                
Release of cumulative foreign currency translation adjustments as a result of sale of Ctrack South Africa (140)                     8         1,608 (1,748) (8)
Share-based compensation 14,467                     14,467              
Series E preferred stock dividends 0                     2,492           (2,492)  
Series E preferred stock exchange 0             $ 2       1,102           (1,104)  
Preferred stock exchange (shares)           (10)   1,525                      
Net noncontrolling interest deconsolidated 125                                 240 (115)
Ending balance at Sep. 30, 2021 (15,332)         $ 0   $ 105       766,736         (7,242) (774,931) 0
Ending Balance (shares) at Sep. 30, 2021           25   104,950                      
Beginning balance at Jun. 30, 2021 (8,906)         $ 0   $ 103       761,412         (6,279) (764,150) 8
Beginning Balance (shares) at Jun. 30, 2021           35   103,109                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Net income (loss) (7,190)                                 (7,190) 0
Foreign currency translation adjustment (2,571)                               (2,571)    
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan 693             $ 0       693              
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan (shares)               316                      
Taxes withheld on net settled vesting of restricted stock units (280)                     (280)              
Release of cumulative foreign currency translation adjustments as a result of sale of Ctrack South Africa (140)                     8         1,608 (1,748) (8)
Share-based compensation 3,062                     3,062              
Series E preferred stock dividends 0                     739           (739)  
Series E preferred stock exchange 0             $ 2       1,102           (1,104)  
Preferred stock exchange (shares)           (10)   1,525                      
Ending balance at Sep. 30, 2021 $ (15,332)         $ 0   $ 105       $ 766,736         $ (7,242) $ (774,931) $ 0
Ending Balance (shares) at Sep. 30, 2021           25   104,950